Search

Filters

Clear Filters
3:10 PM - 3:15 PM ET

1073 - Eliminating Uncertainties in Post-Treatment Breast Cosmesis Evaluation using Vision-Language Artificial Intelligence
Speaker: Park, Sangjoon, MD, PhD - Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul
3:15 PM - 3:20 PM ET

1074 - A Phase II Randomized Blinded Trial of AI-Assisted Versus Manual Contouring by New Learners in Ultrasound-Based Prostate HDR Brachytherapy
Speaker: Thomsen, Bryce, MD - Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA
3:20 PM - 3:25 PM ET

1075 - Auto-Segmented Organ-at-Risk Volume Variability as a Patient-Specific Predictive Biomarker for Gastrointestinal Toxicity Risk Stratification in Abdominal Radiotherapy
Speaker: Lasington, Jeril, MD - NYMC-Saint Clare's Health and Saint Mary's general hospital, Denville, NJ
3:25 PM - 3:30 PM ET

1076 - Spatiotemporal AI Morphometry Predicts Early Recurrence in Rectal Cancer Post-nCRT: A Multi-Model Ablation Study
Speaker: Chen, Shenlun, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:30 PM - 3:35 PM ET

1077 - Dynamic Delta-Radiomics and Clinical Fusion Model for Predicting Disease-Free Survival In Locally Advanced Cervical Cancer: A Multi-Cohort Study
Speaker: Wang, Weiping, MD, PhD - Peking Union Medical College Hospital, Beijing, Beijing
5:05 PM - 5:10 PM ET

1078 - Bone Marrow-Sparing Extended-Field Chemoradiation with Dose-Dense Neoadjuvant Chemotherapy for FIGO 2018 Stage IIIC2 Cervical Cancer: Early Outcomes of a Prospective Phase II Study
Speaker: Saini, Surendra, MD, PhD, DPH;DPH, FESTRO - All India Institute of Medical Sciences, New Delhi
5:10 PM - 5:15 PM ET

1079 - Nab-Paclitaxel plus Cisplatin Concurrent with Image Guided Volumetric Modulated Arc Therapy for Locally Advanced Cervical Cancer: Five-Year Follow-Up Results of a Single-Arm, Prospective Study
Speaker: Wei, Shuhua, PhD - Peking University Third Hospital, Beijing, Beijing
3:30 PM - 3:40 PM ET

108 - Three-Year Outcomes of a Prospective Randomized Trial of Moderately-Hypofractionated and Standard-Fractionated Proton Therapy in Prostate Cancer Embedded within COMPPARE Trial
Speaker: Mendenhall, Nancy, MD, FASTRO - University of Florida Proton Therapy Institute, Jacksonville, FL
5:15 PM - 5:20 PM ET

1080 - Validation of an Automated Segmentation and Planning Reference Generation System for Gynecologic HDR Brachytherapy
Speaker: Marchant, Rebecca, MD - University of California at San Diego, La Jolla, CA
5:20 PM - 5:25 PM ET

1081 - Nab-Paclitaxel and Cisplatin with Image Guided Volumetric Modulated Arc Therapy for Locally Advanced Cervical Cancer: A Multicenter, Single-Arm Phase II Trial
Speaker: Wei, Shuhua, PhD - Peking University Third Hospital, Beijing, Beijing
5:25 PM - 5:30 PM ET

1082 - Contrast-Free Virtual Enhancement: Multi-Modal Deep Learning Synthesis of CECT from pCT and MRI
Speaker: Chen, Jian, PhD - Cancer Hospital of Shandong First Medical University, Shandong
5:30 PM - 5:35 PM ET

1083 - Prospective Two-Year Progression-Free Survival and Toxicity after Daily Online Adaptive Radiotherapy for Cervical Cancer
Speaker: Wang, Guangyu, MD - Peking Union Medical College Hospital, Beijing, Beijing